Novartis signs mRNA deal for about $7.8 billion with China’s Abogen

🇨🇳 Investing.com (CN) —
Novartis signs mRNA deal for about $7.8 billion with China’s Abogen

AI Summary

Novartis has signed an mRNA-related deal with China-based Abogen valued at about $7.8 billion. The agreement links a major pharmaceutical company with a biotechnology firm working in mRNA.

Markets Deals Health Novartis Abogen mRNA biotechnology pharmaceutical deal $7.8 billion

Read original source →